Home / Recalls / Partell Specialty Pharmacy / D-0682-2018

D-0682-2018 Class II Terminated

Recalled by Partell Specialty Pharmacy — Las Vegas, NV

Recall Details

Product Type
Drugs
Report Date
April 25, 2018
Initiation Date
March 22, 2018
Termination Date
January 15, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity

Product Description

Testosterone/Finasteride 80 mg/8 mg pellet, amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.

Reason for Recall

Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.

Distribution Pattern

NV only

Code Information

20180110@57, 20180110@23 BUD 07/09/2018, 20171003@91, BUD 04/01/2018, 20171016@24, BUD 04/14/2018.

Other recalls by Partell Specialty Pharmacy

  • D-0653-2018 Class II — Testosterone/Finasteride 60 mg/5 mg pellet Amber vial, Rx only, Partell Specialt (March 22, 2018)
  • D-0657-2018 Class II — Testosterone Propionate 100mg/mL, 5 mL amber vial, Rx only, Partell Specialty (March 22, 2018)
  • D-0681-2018 Class II — Estradiol 55 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, (March 22, 2018)
  • D-0672-2018 Class II — Testosterone/Anastrozole 60 mg/4 mg pellets packaged in amber vial, Rx only, Par (March 22, 2018)
  • D-0677-2018 Class II — Estradiol 25 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmacy, (March 22, 2018)
  • D-0643-2018 Class II — Nandrolone decanoate 200mg/mL, 5 mL amber vial, Rx only, Partell Specialty Pharm (March 22, 2018)
  • D-0655-2018 Class II — Methylcobalamin 12.5 mg/mL, Injectable Liquid, packaged in a) 5 mL amber vial, a (March 22, 2018)
  • D-0666-2018 Class II — Testosterone 40 mg pellet packaged in amber vial, Rx only, Partell Specialty P (March 22, 2018)
  • D-0647-2018 Class II — Methionine 25mg/Inositol 50mg/Choline 50mg/ B12 1mg, 50 mL amber vial, Rx only, (March 22, 2018)
  • D-0674-2018 Class II — Estradiol 12.5 mg (SD) pellets in amber vial, Rx only, Partell Specialty Pharmac (March 22, 2018)